Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result-Reference-Cited by-同舟云学术

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result

Published:2016-10 Issue:5 Volume:42 Page:925-931
ISSN:1677-5538
Container-title:International braz j urol
language:
Short-container-title:Int. braz j urol.

Author:

Fiamegos Alexandros¹,Varkarakis John¹,Kontraros Michael¹,Karagiannis Andreas¹,Chrisofos Michael¹,Barbalias Dimitrios¹,Deliveliotis Charalampos¹

Affiliation:

1. University of Athens, Greece

Publisher

FapUNIFESP (SciELO)

Subject

Urology

Link

http://www.scielo.br/pdf/ibju/v42n5/1677-5538-ibju-42-05-0925.pdf

Reference36 articles.

1. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide;Ferlay J,2004

2. Human prostate cancer risk factors;Bostwick DG;Cancer,2004

3. Hormones and prostate cancer: what's next?;Hsing AW;Epidemiol Rev.,2001

4. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer;Platz EA;J Steroid Biochem Mol Biol.,2004

5. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration;Noble RL;Cancer Res.,1977

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New generation biomarkers for the detection of prostate cancer;Biosensors and Bioelectronics: X;2022-12

2. Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosis;Advances in Cancer Biology - Metastasis;2022-10

3. Are higher pre‐diagnosis follicle stimulating hormone levels associated with long‐term prostate cancer risk?;The Prostate;2022-08-18

4. Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors;Biosensors and Bioelectronics;2019-07

5. The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia;International braz j urol;2018-02